|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
82,270,000 |
Market
Cap: |
233.65(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$2.67 - $32.15 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 8.1 |
Insider 6 Months : 8.1 |
Insider 3/6 Months : 16.7 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Revance Therapeutics is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. Co.'s segments are: Product, which refers to the business that includes the research, development and commercialization of its product candidates and the RHA® Collection of dermal fillers; and Service, which refers to the business that includes the development and commercialization of the OPUL Relational Commerce Platform and HintMD platform.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
30,000 |
30,000 |
30,000 |
30,000 |
Total Buy Value |
$209,400 |
$209,400 |
$209,400 |
$209,400 |
Total People Bought |
1 |
1 |
1 |
1 |
Total Buy Transactions |
1 |
1 |
1 |
1 |
Total Shares Sold |
29,089 |
29,089 |
154,980 |
446,160 |
Total Sell Value |
$143,717 |
$143,717 |
$3,177,942 |
$12,719,522 |
Total People Sold |
4 |
4 |
5 |
5 |
Total Sell Transactions |
4 |
4 |
12 |
27 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Gardner Phyllis |
Director |
|
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
10,500 |
|
- |
|
Byrnes Robert F |
Director |
|
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
10,500 |
|
- |
|
Gangolli Julian S |
Director |
|
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
10,500 |
|
- |
|
Foley Mark J |
Director |
|
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
13,500 |
|
- |
|
Browne L Daniel |
CEO and President |
|
2019-03-18 |
4 |
AS |
$15.51 |
$180,068 |
D/D |
(11,613) |
151,193 |
|
- |
|
Allouche Cyril |
Principal Accounting Officer |
|
2019-03-18 |
4 |
AS |
$15.48 |
$7,709 |
D/D |
(498) |
6,400 |
|
- |
|
Browne L Daniel |
CEO and President |
|
2019-03-15 |
4 |
D |
$15.45 |
$94,817 |
D/D |
(6,137) |
162,806 |
|
- |
|
Allouche Cyril |
Principal Accounting Officer |
|
2019-03-15 |
4 |
D |
$15.45 |
$3,893 |
D/D |
(252) |
6,898 |
|
- |
|
Joshi Abhay |
Chief Operating Officer |
|
2019-03-15 |
4 |
D |
$15.45 |
$20,919 |
D/D |
(1,354) |
88,923 |
|
- |
|
Joshi Abhay |
Chief Operating Officer |
|
2019-03-14 |
4 |
D |
$15.59 |
$2,588 |
D/D |
(166) |
90,277 |
|
- |
|
Joshi Abhay |
Chief Operating Officer |
|
2019-03-14 |
4 |
OE |
$4.20 |
$2,797 |
D/D |
666 |
90,443 |
|
- |
|
Browne L Daniel |
CEO and President |
|
2019-02-19 |
4 |
AS |
$17.68 |
$96,285 |
D/D |
(5,446) |
168,943 |
|
- |
|
Browne L Daniel |
CEO and President |
|
2019-02-15 |
4 |
D |
$17.69 |
$55,794 |
D/D |
(3,154) |
174,389 |
|
- |
|
Joshi Abhay |
Chief Operating Officer |
|
2019-02-15 |
4 |
D |
$17.69 |
$26,712 |
D/D |
(1,510) |
89,777 |
|
- |
|
Schilke Tobin |
CFO |
|
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
23,000 |
|
- |
|
Browne L Daniel |
CEO and President |
|
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
177,543 |
|
- |
|
Joshi Abhay |
Chief Operating Officer |
|
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
15,750 |
91,287 |
|
- |
|
Allouche Cyril |
Principal Accounting Officer |
|
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,150 |
7,150 |
|
- |
|
Mcdowell Caryn Gordon |
SVP, GC & Secretary |
|
2019-01-24 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
24,318 |
|
- |
|
Allouche Cyril |
Principal Accounting Officer |
|
2019-01-22 |
4 |
AS |
$17.77 |
$11,106 |
D/D |
(625) |
4,000 |
|
- |
|
Allouche Cyril |
Principal Accounting Officer |
|
2019-01-22 |
4 |
OE |
$13.35 |
$8,344 |
D/D |
625 |
4,625 |
|
- |
|
Joshi Abhay |
Chief Operating Officer |
|
2019-01-15 |
4 |
D |
$20.19 |
$90,169 |
D/D |
(4,466) |
75,537 |
|
- |
|
Allouche Cyril |
Principal Accounting Officer |
|
2019-01-03 |
4 |
AS |
$19.48 |
$7,305 |
D/D |
(375) |
4,000 |
|
- |
|
Mcdowell Caryn Gordon |
SVP, GC & Secretary |
|
2018-12-31 |
4 |
A |
$17.11 |
$13,996 |
D/D |
818 |
16,818 |
|
- |
|
Allouche Cyril |
Principal Accounting Officer |
|
2018-12-31 |
4 |
A |
$17.11 |
$6,416 |
D/D |
375 |
4,375 |
|
- |
|
422 Records found
|
|
Page 9 of 17 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|